After decades of struggling to find a way to treat pancreatic cancer, researchers have developed several promising new drugs ...

Researchers at the University of Colorado Anschutz may have identified why many cancer patients say food suddenly tastes ...

New experimental medications seem to extend survival with the hard-to-treat cancer.

Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...

Many breast cancer drugs block estrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis. But most patients with advanced disease eventually ...

Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.

This chapter of this background paper describes the Food and Drug Administration’s (FDA) statutory authority and responsibility for new therapeutics, FDA programs begun as a result of legislative ...

In a difficult disease, Revolution Medicines achieved what the pancreatic cancer community has long desired: a significant improvement in survival. The Phase 3 results will support global regulatory ...

The protein is implicated in a wide swath of cancers, but harnessing it for drug R&D is still a major scientific challenge.